News

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
E ver since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...
US President Donald Trump signed an executive order requiring drugmakers to lower prices, aligning with international rates.
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...
The Trump administration is pushing for reduced prices on weight-loss drugs like Wegovy and Zepbound, citing stark pricing ...
Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...
As a Biden administration ban on so-called “junk fees” took effect Monday, Ticketmaster said it would start displaying the ...
The regulator's letter warns of new scrutiny on Ergen's EchoStar and considers opening satellite spectrum to rivals including SpaceX. The move is a sign of increased investor excitement about AI's ...
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...